BIOSCRIP INC's ticker is BIOSXXXX and the CUSIP is 09069N108. A total of 118 filers reported holding BIOSCRIP INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $27,000 | +350.0% | 10,438 | +485.1% | 0.00% | – |
| Q4 2018 | $6,000 | +100.0% | 1,784 | +104.4% | 0.00% | – |
| Q3 2018 | $3,000 | 0.0% | 873 | -2.9% | 0.00% | – |
| Q2 2018 | $3,000 | +200.0% | 899 | +16.0% | 0.00% | – |
| Q4 2016 | $1,000 | -50.0% | 775 | 0.0% | 0.00% | – |
| Q3 2016 | $2,000 | 0.0% | 775 | -1.6% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 788 | +1.7% | 0.00% | – |
| Q1 2016 | $2,000 | -99.5% | 775 | -99.2% | 0.00% | -100.0% |
| Q1 2015 | $441,000 | -36.6% | 99,518 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $696,000 | +1.2% | 99,518 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $688,000 | -18.3% | 99,518 | -1.4% | 0.00% | 0.0% |
| Q2 2014 | $842,000 | +37.8% | 100,918 | +15.2% | 0.00% | 0.0% |
| Q1 2014 | $611,000 | -18.9% | 87,569 | -14.0% | 0.00% | 0.0% |
| Q4 2013 | $753,000 | -93.0% | 101,770 | -91.6% | 0.00% | -94.1% |
| Q3 2013 | $10,699,000 | +51.6% | 1,218,489 | +184.9% | 0.02% | +30.8% |
| Q2 2013 | $7,056,000 | – | 427,637 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KEANE CAPITAL MANAGEMENT INC | 894,943 | $3,965,000 | 3.86% |
| DSC Advisors, L.P. | 1,200,000 | $5,316,000 | 2.82% |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 2,208,710 | $9,785,000 | 1.96% |
| ARDSLEY ADVISORY PARTNERS LP | 3,010,000 | $13,335,000 | 1.85% |
| First Washington CORP | 709,600 | $3,144,000 | 1.82% |
| WYNNEFIELD CAPITAL INC | 505,500 | $2,239,000 | 0.99% |
| Camber Capital Management LP | 3,000,000 | $13,290,000 | 0.95% |
| MARATHON CAPITAL MANAGEMENT | 478,800 | $2,121,000 | 0.94% |
| KING INVESTMENT ADVISORS INC/TX | 315,040 | $1,402,000 | 0.67% |
| THB ASSET MANAGEMENT | 2,082,955 | $9,227,000 | 0.64% |